[en] This study was undertaken in order to examine the estrogen sensitivity of HKT-1097, an established cell line recently derived from diethylstilbestrol (DES)-induced kidney tumors in Syrian hamsters. Estrogen receptor (ER) level in HKT-1097, determined by enzyme-linked immunoassay, was 67 fmol/mg protein, i.e., a value approx. 30% lower than that found in Syrian hamster kidney tumors. ER immunostaining in cells fixed with Carnoy's mixture, as well as ER demonstration by Western blotting, suggested DES-induced nuclear translocation or stabilization of the receptor within the nucleus. Kinetic parameters of estrogen binding to ER in HKT-1097 cells were 8.4 x 10(-11) M and 60.8 fmol/mg protein for Kd and Bmax, respectively. The Kd of estrogen binding to ER in HKT-1097 was close to that evaluated for the receptor in breast cancer-derived MCF-7 cell line, whereas the Bmax value was approx. seven times lower in HKT-1097 as compared to MCF-7. In HKT-1097 cells, antiestrogens ICI 182,780 and RU 58,668 induced ER downregulation and competed with estrogen binding to the receptor. As demonstrated by Western blot analysis, DES exposure led to an increased expression of progesterone receptor (PgR) in HKT-1097 cells. Addition of DES to estrogen-free medium produced a stimulation of growth in both HKT-1097 and MCF-7 cells, but the mitogenic effect was less marked for HKT-1097. Despite the fact that ICI 182,780 and RU 58,668 clearly interact with HKT-1097 cell ER, they appeared unable to suppress DES-induced stimulation of growth and increase of PgR expression
Disciplines :
Education & instruction
Author, co-author :
Brohée, Régine
Nonclercq, Denis ; Université de Mons > Faculté de Médecine et de Pharmacie > FMP - Service du Doyen
Chauchereau A., Savouret J.F., Milgrom E. (1992) Control of biosynthesis and post-transcriptional modification of the progesterone receptor. Biol. Reprod. 46:174-177.
Cortes-Vizcaino V., Peydro-Olaya A., Llombart-Bosch A. (1994) Morphological and immunohistochemical support for the interstitial cell origin of oestrogen-induced kidney tumours in the Syrian golden hamster. Carcinogenesis 15:2155-2162.
Dumont J.A., Bitonti A.J., Wallace C.D., Baumann R.J., Cashman E.A., Cross-Doersen D.E. (1996) Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ. 7:351-359.
Gasc J.-M., Baulieu E.E. (1987) From the structure of steroid receptors to their assessment by immunocytochemistry target cells. J. Steroid Biochem. 27:177-184.
Jensen B.L., Skouv J., Lundholt B.K., Lykkesfeldt A.E. (1999) Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6. Br. J. Cancer 79:386-392.
Jensen E.V., Suzuki T., Kawashima T., Stumpf W.E., Jungblut P.W., DeSombre E.R. (1968) A two step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. USA 59:632-638.
Jin L., Borras M., Lacroix M., Legros N., Leclercq G. (1995) Antiestrogenic activity of two 11β-estradiol derivatives on MCF-7 breast cancer cells. Steroids 60:512-518.
Kirkman A., Bacon R.L. (1950) Malignant renal tumors in male hamsters “Cricetus auratus” treated with estrogen. Cancer Res. 10:122-124.
Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
Larsen S.S., Madsen M.W., Jensen B.L., Lykkesfeldt A.E. (1997) Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI , 182 780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness. Int. J. Cancer 72:1129-1136.
Laurent G., Nonclercq D., Journe F., Brohee R., Toubeau G., Falmagne P., Heuson-Stiennon J.-A. (1999) Characterization of a cell line established from diethylstilbestrol-inducedrenal tumors in Syrian hamsters. In Vitro Cell Dev. Biol. 35 A:339-345.
Levin E., Actis A.M., Lopez S. (1993) Characterization of rat uterine estrogen receptors in vivo. J. Steroid Biochem. Mol. Biol. 44:277-285.
Li J.J., Hou X., Bentel J., Yazlovitskaya E.M., Li S.A. (1998) Prevention of estrogen carcinogenesis in the hamster kidney by ethinylestradiol: Some unique properties of a synthetic estrogen. Carcinogenesis 19:471-477.
Li J.J., Li S.A. (1996) Estrogen carcinogenesis in the hamster kidney: A hormone-driven multistep process. Prog. Clin. Biol. Res. 394:255-267.
Li J.J., Li S.A., Oberley T.D., Parsons J.A. (1995) Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: Relation to hormonal activity and cell proliferation. Cancer Res. 55:4347-4351.
Li S.A., Li J.J. (1978) Estrogen-induced progesterone receptor in the Syrian hamster kidney. I. Modulation by antiestrogens and androgens. Endocrinology 103:2119-2128.
Liehr J.G., Chiapetta C., Roy D., Stancel G.M. (1992) Elevation of protooncogene messenger RNAs in estrogen-induced kidney tumors in the hamster. Carcinogenesis 13:601-604.
Liehr J.G., Folse D.S., Roy D. (1992) Lack of effectiveness of antiestrogens RU 39,411 or keoxifene in the prevention of estrogen-induced tumors in Syrian hamsters. Cancer Lett. 64:23-29.
Liehr J.G., Sirbasku D.A., Jurka E., Randerath K., Randerath E. (1988) Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by tamoxifen without decrease in DNA adduct levels. Cancer Res. 48:779-783.
Nonclercq D., Toubeau G., Wattiez R., Laurent G., Bernard A., Journe F., Falmagne P., Heuson-Stiennon J.-A. (1998) Sublethal alterations and sustained cell proliferation associated with the diethylstilbestrol-induced renal carcinogenesis in male Syrian golden hamsters. Eur. J. Morphol. 36:83-96.
Olea-Serrano N., Devleeschouwer N., Leclercq G., Heuson J.C. (1985) Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture. Eur. J. Cancer Clin. Oncol. 21:965-973.
Parikh I., Rajendran K.G., Su J.-L., Lopez T., Sar M. (1987) Are estrogen receptors cytoplasmic or nuclear? Some immunocytochemical and biochemical studies. J. Steroid Biochem. 27:185-192.
Press M.F., Xu S.H., Wang J.D., Greene G.L. (1989) Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand. Am. J. Pathol. 135:857-864.
Raam S., Lauretano A.M., Vrabel D.M., Pappas C.A., Tamura H. (1988) Nuclear localization of hormone-free estrogen receptors by monoclonal antibodies could be a tissue-fixation dependent artifact. Steroids 51:425-439.
Raam S., Richardson G.S., Bradley F., MacLaughlin D., Sun L., Frankel F., Cohen J.L. (1983) Translocation of cytoplasmic estrogen receptors to the nucleus: Immunocytochemical demonstration utilizing rabbit antibodies to estrogen receptors of mammary carcinomas. Breast Cancer Res. Treat. 3:179-199.
Scatchard G. (1949) Attractions of protein for small molecules and ions. Ann. NY Acad. Sci. 51:600-672.
Sierralta W.D., Bonig I., Thole H.H. (1995) Immunogold labelling of estradiol receptor in MCF7 cells. Cell Tissue Res. 279:445-452.
Sierralta W.D., Jakob F., Thole H., Engel P., Jungblut P.W. (1992) Estradiol-promoted accumulation of receptor in nuclei of porcine endometrium cells. Immunogold electron microscopy of resting and estradiol-stimulated cells. Receptor 2:29-37.
Sirbasku D.A. (1978) Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary, and kidney tumor cells. Proc. Natl. Acad. Sci. USA 75:3786-3790.
Sirbasku D.A., Kirkland W.L. (1976) Control of cell growth. IV. Growth properties of a new cell line established from an estrogen-dependent kidney tumor of the Syrian hamster. Endocrinology 98:1260-1272.
Smith P.K., Krohn R.I., Hermanson G.T. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
Van de Velde P., Nique F., Bouchoux F. (1994) RU 58,668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice. J. Steroid. Biochem. Mol. Biol. 48:187-196.
Wakeling A.E., Dukes M., Bowler J. (1991) A potent specific pure antiestrogen with clinical potential. Cancer Res. 51:3867-3873.
Welshons W.V., Cormier E.M., Wolf M.F., Williams P.O., Jordan V.C. (1988) Estrogen receptor distribution in enucleated breast cancer cell lines. Endocrinology 122:2379-2386.
Welshons W.V., Grady L.H., Judy B.M., Jordan V.C., Preziosi D.E. (1993) Subcellular compartmentalization of MCF-7 estrogen receptor synthesis and degradation. Mol. Cell. Endocrinol. 94:183-194.
